Ampliando los horizontes del intervenc ionismo en la terapia vascular: Visión futura Dr. Martín León

More articles by this author

Conferencia del Dr. Qureshi

Conferencia del Dr. Qureshi

Stent Thrombosis: a note of caution Dr. Conrad Simpfendorfer

Stent Thrombosis: a note of caution Dr. Conrad Simpfendorfer

Dosis de clopidogrel: ¿300 mg, 600 mg, 900 mg, o más? Dr. Neil Kleiman

Dosis de clopidogrel: ¿300 mg, 600 mg, 900 mg, o más? Dr. Neil Kleiman

Angioplastia para Oclusión Total Crónica Dr. Shigeru Saito

Angioplastia para Oclusión Total Crónica Dr. Shigeru Saito

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....